Prevalence, risk factors and management of ocular hypertension or glaucoma in patients with Vogt-Koyanagi-Harada disease

医学 青光眼 伏格特-小柳-原田病 眼科 高眼压 眼压 葡萄膜炎 视力 回顾性队列研究 并发症 风险因素 病历 眼病 青光眼药物治疗 外科 内科学
作者
Peizeng Yang,Chaokui Wang,Guannan Su,Su Pan,Qin Yang,Jun Zhang,Qingfeng Cao,Zhenyu Zhong,Chunjiang Zhou,Yao Wang,Aize Kijlstra
出处
期刊:British Journal of Ophthalmology [BMJ]
卷期号:105 (12): 1678-1682 被引量:15
标识
DOI:10.1136/bjophthalmol-2020-316323
摘要

Background/aims This study was performed to examine the prevalence, risk factors and treatment outcome of OHT/glaucoma in Chinese patients with Vogt-Koyanagi-Harada (VKH). Methods Retrospective non-interventional case series were conducted on a total of 2281 patients with VKH referred from April 2008 to April 2019. Of these cases, 1457 had a minimum follow-up period of 3 months and were included for this study. Medical records were reviewed for demographic, ocular and treatment data. Results Among 2914 eyes of 1457 patients with VKH, 695 (23.9%) eyes of 425 patients (29.2%) developed OHT/glaucoma. The risk factors of OHT/glaucoma included initial BCVA of 20/200 or worse (OR=4.826), final best-corrected visual acuity (BCVA) of 20/50–20/100 (OR=5.341) and final BCVA of 20/200 or worse (OR=4.235), the interval between uveitis attack and referral time interval being 2 months or more (OR=3.318), more than three recurrent episodes (OR=4.177) and posterior synechiae (OR=1.785). The main possible mechanisms of OHT/glaucoma were inflammatory factor-induced open-angle OHT/glaucoma in 277 eyes (39.9%) and pupillary block arising from complete posterior synechiae in 201 eyes (28.9%). In these 695 eyes with OHT/glaucoma, normalised intraocular pressure (IOP) was achieved in 389 eyes (56.0%) following medical treatment. In the remaining 306 eyes, various surgical interventions were performed and a normalised IOP could be achieved in 249 eyes (81.4%). Conclusion OHT/glaucoma is a common complication in Chinese patients with VKH. Risk factors of OHT/glaucoma included worse acuity at first and final visits, the longer interval between uveitis attack and referral, more recurrent episodes and posterior synechiae.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
隐形曼青应助Sean采纳,获得10
刚刚
数羊世一完成签到,获得积分10
1秒前
1秒前
1秒前
wjincyvy完成签到 ,获得积分10
2秒前
宁艺卓完成签到,获得积分10
2秒前
csd发布了新的文献求助10
3秒前
juanjuan发布了新的文献求助10
3秒前
乃惜发布了新的文献求助30
4秒前
Sia31完成签到,获得积分20
4秒前
Hello应助成就蚂蚁采纳,获得10
4秒前
沉静易形发布了新的文献求助10
5秒前
研友_ZGDVz8完成签到,获得积分10
5秒前
RED发布了新的文献求助10
5秒前
ouy发布了新的文献求助10
5秒前
5秒前
cai发布了新的文献求助10
5秒前
7秒前
7秒前
7秒前
7秒前
www发布了新的文献求助10
8秒前
乐乐应助小小学神采纳,获得10
8秒前
淡然若完成签到 ,获得积分10
8秒前
小妮发布了新的文献求助10
9秒前
斯文的白玉应助气炸的欧采纳,获得10
11秒前
老的火龙果应助气炸的欧采纳,获得10
11秒前
11秒前
skyzhy应助Sean采纳,获得10
11秒前
12秒前
芒果发布了新的文献求助10
12秒前
choale完成签到,获得积分10
13秒前
Paul111发布了新的文献求助10
13秒前
丘比特应助火星上的闭月采纳,获得10
13秒前
核桃发布了新的文献求助30
14秒前
FOB应助黙宇循光采纳,获得10
15秒前
仄言发布了新的文献求助10
15秒前
16秒前
英俊的铭应助cai采纳,获得10
17秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Encyclopedia of Cardiovascular Research and Medicine(2e) 820
自動車の空力技術 800
Essentials of Carbohydrate Chemistry and Biochemistry, 4th Edition 800
Organizational Behavior 510
Management and the Arts 510
Matrix Methods in Data Mining and Pattern Recognition Second Edition 510
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 化学工程 工程类 有机化学 物理 复合材料 生物化学 内科学 细胞生物学 基因 遗传学 免疫学 冶金 光电子学 癌症研究
热门帖子
关注 科研通微信公众号,转发送积分 7781325
求助须知:如何正确求助?哪些是违规求助? 9321119
关于积分的说明 20381559
捐赠科研通 7369042
什么是DOI,文献DOI怎么找? 3320035
关于科研通互助平台的介绍 2467813
邀请新用户注册赠送积分活动 2335891